- Activity pressure is positive on the latest completed week.
- Volume is elevated versus the 13-week average, confirming attention.
CYH
NYSE
Week ended 24 Jul 2026
Weekly Investor Report
Community Health Systems Inc · Healthcare · Medical Care Facilities
Latest close
2.73 USD
-17.3%
latest week
Weekly setup
Weak trend
The weekly trend is not active. Price is -12.6% below the Trend Line and sits at 16.9% of its 52-week range. The latest completed week returned -17.3%, after a -16.8% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is inexpensive relative to peers. Options positioning is volatility with 60/100 conviction, while the latest news-sentiment score is 43/100. Near-term considerations: earnings are due in 84d.
Setup score
35
out of 100
Latest Close
2.73 USD
24 Jul 2026
1W Return
-17.3%
latest completed week
4W Return
-16.8%
short-term follow-through
12W Return
-8.4%
quarterly tape
Trend Breadth
25.0%
13 of 52 weeks active
Volume Ratio
2.0x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is weak, so confirmation is not yet broad enough.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-17.3%
Latest completed week; four-week move -16.8%.
Indicator stack
14/100
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Options pressure
Volatility
60/100 conviction; expected move 15.6%.
News sentiment
43/100
63 relevant articles in the latest sentiment read.
Event risk
84d
Next report is scheduled for 22 Oct 2026; event risk rises as the date approaches.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -12.6% below the Trend Line and sits at 16.9% of its 52-week range. The latest completed week returned -17.3%, after a -16.8% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 2.0x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
30 Jan
6 Feb
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.2612-week average 0.09
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure5/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership2/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.26Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -16.8% over four weeks, -8.4% over 12 weeks, and -1.4% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year13
Trend breadth25.0%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.97Latest activity-pressure read.
Pressure change7108.2%Four-week change in activity pressure.
Leadership-19.43Latest relative-leadership reading.
RS change-494.9%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is inexpensive relative to peers.
Factor week 26 Jul 2026
Financial statements through 31 Dec 2025
Field coverage 85%
Model confidence 85%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength91/100Blend of value, momentum, and quality. Underlying universe rank 10; rank 1 is best.
Value92/100Relative valuation strength. Underlying universe rank 9; rank 1 is best.
Quality90/100Profitability and accounting quality. Underlying universe rank 11; rank 1 is best.
Momentum31/100Medium-term price momentum. Underlying universe rank 70; rank 1 is best.
Growth75/100Revenue and earnings growth. Underlying universe rank 26; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- - Price divided by trailing earnings.
- Price / sales
- 0.0x Market value relative to trailing revenue.
- EV / EBITDA
- 2.2x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- 4.0% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 58.1% Gross profit retained from each unit of revenue.
- Operating margin
- 19.4% Operating profit retained from revenue.
- Free-cash-flow margin
- 1.9% Free cash flow generated from revenue.
- Return on invested capital
- 37.6% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 77.2% Latest one-year revenue growth.
- EPS growth
- - Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- -48.3% Latest one-year free-cash-flow growth.
- Piotroski F-score
- 7/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- - Cash dividends relative to market value.
- Buyback yield
- 0.5% Net share repurchases relative to market value.
- Shareholder yield
- 0.5% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 2.0x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Options positioningVolatility
CYH shows volatility options pressure with a 60/100 conviction score, put-call volume ratio of 0.00, expected move of 15.6%, and Sharemaestro trend signal inactive.
Conviction60/100
Expected move15.6%
Put/call volume0.00
Insider activity5 / 2
5 acquisitions and 2 disposals in the latest 180-day insider tape.
Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.News sentiment43/100
Weighted news tone is neutral across 63 relevant articles.
5 positive · 36 neutral · 22 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings84dNext report is scheduled for 22 Oct 2026; event risk rises as the date approaches.
Options expected move15.6%Nearest-chain priced movement where available.
52-week drawdown-38.4%Distance below the 52-week high.
13-week volatility9.6%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
30 Jan
27 Feb
27 Mar
24 Apr
22 May
19 Jun
24 Jul
Weeks higher11 of 2615 weeks finished lower.
Best week+18.9%Week of 3 Jul.
Worst week-17.3%Week of 24 Jul.
Latest week-17.3%Week of 24 Jul.
Shape of recent returns
Strong gains7
Modest gains4
Flat weeks0
Modest losses8
Sharp losses7
Recent vol9.6%13-week weekly-return volatility.
Base vol8.4%52-week weekly-return volatility.
Up/down split25/26Count of positive and negative weeks in the 52-week window.
Average skew6.6% / -5.7%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorUS Healthcare
4-week rank- / 100
Group average1.3%
Trend breadth51.0%
Trend51.0%active weekly trend signals
MD75.0%positive activity pressure
RS48.0%positive relative leadership
Four-week leaders
IndustryUS Medical Care Facilities
4-week rank43 / 45
Group average1.8%
Trend breadth71.1%
Trend71.1%active weekly trend signals
MD86.7%positive activity pressure
RS53.3%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape38/100
Trend, activity pressure, participation, and risk combine to a 38/100 tape read.
Indicator analysis25/100Latest 12-week confirmation: trend 0/12, activity pressure 5/12, relative leadership 2/12.
Activity pressure 0.26; No reversal markers Factors77/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 35; Small Cap Core rank 13 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Options38/100CYH shows volatility options pressure with a 60/100 conviction score, put-call volume ratio of 0.00, expected move of 15.6%, and Sharemaestro trend signal inactive.
Volatility · Volatility expansion watch · Expected move 15.6% Sentiment43/100Weighted news tone is neutral across 63 relevant articles.
Community Health Systems Inc (CYH) Institutional Confidence Insiders5 / 25 acquisitions and 2 disposals in the latest 180-day insider tape.
Earnings84dNext report is scheduled for 22 Oct 2026; event risk rises as the date approaches.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 24 Jul 2026 | 2.73 USD | -17.3% | 3.12 USD | 3.40 USD | 0.97 | -19.43 | 17.2M | Off |
| 17 Jul 2026 | 3.30 USD | -7.6% | 3.14 USD | 3.41 USD | 1.17 | -3.46 | 11.7M | Off |
| 10 Jul 2026 | 3.57 USD | -8.5% | 3.14 USD | 3.42 USD | 0.96 | 2.25 | 7.7M | Off |
| 3 Jul 2026 | 3.90 USD | 18.9% | 3.13 USD | 3.42 USD | 0.71 | 12.71 | 8.2M | Off |
| 26 Jun 2026 | 3.28 USD | 8.6% | 3.12 USD | 3.43 USD | 0.01 | -3.27 | 8.5M | Off |
| 19 Jun 2026 | 3.02 USD | -3.2% | 3.12 USD | 3.44 USD | -0.64 | -13.43 | 5.0M | Off |
| 12 Jun 2026 | 3.12 USD | 13.9% | 3.13 USD | 3.44 USD | -1.00 | -10.32 | 7.5M | Off |
| 5 Jun 2026 | 2.74 USD | 0.7% | 3.13 USD | 3.45 USD | -1.30 | -21.19 | 7.7M | Off |
| 29 May 2026 | 2.72 USD | -2.9% | 3.17 USD | 3.45 USD | -1.23 | -24.61 | 5.2M | Off |
| 22 May 2026 | 2.80 USD | -0.7% | 3.20 USD | 3.46 USD | -1.02 | -22.23 | 6.7M | Off |
| 15 May 2026 | 2.82 USD | 1.1% | 3.25 USD | 3.46 USD | -0.87 | -21.81 | 5.8M | Off |
| 8 May 2026 | 2.79 USD | -6.4% | 3.26 USD | 3.47 USD | -0.79 | -23.56 | 8.3M | Off |
| 1 May 2026 | 2.98 USD | 9.6% | 3.26 USD | 3.47 USD | -0.70 | -17.23 | 10.5M | Off |
| 24 Apr 2026 | 2.72 USD | -13.9% | 3.27 USD | 3.47 USD | -0.84 | -24.01 | 20.3M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.